OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunology of Aging and Cancer Development
Tamàs Fülöp, Anis Larbi, Rami Kotb, et al.
Interdisciplinary topics in gerontology and geriatrics (2013), pp. 38-48
Closed Access | Times Cited: 32
Tamàs Fülöp, Anis Larbi, Rami Kotb, et al.
Interdisciplinary topics in gerontology and geriatrics (2013), pp. 38-48
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
The integration of inflammaging in age-related diseases
Tamàs Fülöp, Jacek M. Witkowski, Fabiola Olivieri, et al.
Seminars in Immunology (2018) Vol. 40, pp. 17-35
Closed Access | Times Cited: 286
Tamàs Fülöp, Jacek M. Witkowski, Fabiola Olivieri, et al.
Seminars in Immunology (2018) Vol. 40, pp. 17-35
Closed Access | Times Cited: 286
The interplay between immunosenescence and age-related diseases
Florencia María Barbé‐Tuana, Giselle A. Funchal, Carine Raquel Richter Schmitz, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 545-557
Open Access | Times Cited: 254
Florencia María Barbé‐Tuana, Giselle A. Funchal, Carine Raquel Richter Schmitz, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 545-557
Open Access | Times Cited: 254
Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment
Hadi Goubran, Rami Kotb, Julie Stakiw, et al.
Cancer Growth and Metastasis (2014) Vol. 7, pp. CGM.S11285-CGM.S11285
Open Access | Times Cited: 190
Hadi Goubran, Rami Kotb, Julie Stakiw, et al.
Cancer Growth and Metastasis (2014) Vol. 7, pp. CGM.S11285-CGM.S11285
Open Access | Times Cited: 190
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV
Jessica L. Castilho, Aihua Bian, Cathy A. Jenkins, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 6, pp. 854-862
Open Access | Times Cited: 50
Jessica L. Castilho, Aihua Bian, Cathy A. Jenkins, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 6, pp. 854-862
Open Access | Times Cited: 50
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
Danay Saavedra, Beatriz García Verdecia, Patricia Lorenzo-Luaces, et al.
Cancer Immunology Immunotherapy (2015) Vol. 65, Iss. 1, pp. 37-45
Closed Access | Times Cited: 67
Danay Saavedra, Beatriz García Verdecia, Patricia Lorenzo-Luaces, et al.
Cancer Immunology Immunotherapy (2015) Vol. 65, Iss. 1, pp. 37-45
Closed Access | Times Cited: 67
Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to Mycobacterium tuberculosis Infection
William P. Lafuse, Murugesan V. S. Rajaram, Qian Wu, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 8, pp. 2252-2264
Open Access | Times Cited: 52
William P. Lafuse, Murugesan V. S. Rajaram, Qian Wu, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 8, pp. 2252-2264
Open Access | Times Cited: 52
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
Raquel Tarazona, Beatriz Sánchez-Correa, Ignacio Casas-Avilés, et al.
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 2, pp. 233-245
Closed Access | Times Cited: 43
Raquel Tarazona, Beatriz Sánchez-Correa, Ignacio Casas-Avilés, et al.
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 2, pp. 233-245
Closed Access | Times Cited: 43
Senescent T Cells in Age-Related Diseases
Pei-Jie Yu, Mei Zhou, Yan Liu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Pei-Jie Yu, Mei Zhou, Yan Liu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 4
Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours
H. Herin, Sandrine Aspeslagh, Eduardo Castañón, et al.
European Journal of Cancer (2018) Vol. 95, pp. 68-74
Closed Access | Times Cited: 32
H. Herin, Sandrine Aspeslagh, Eduardo Castañón, et al.
European Journal of Cancer (2018) Vol. 95, pp. 68-74
Closed Access | Times Cited: 32
Helminth infections and immunosenescence: The friend of my enemy
Amir Abdoli, Hoda Mirzaian Ardakani
Experimental Gerontology (2020) Vol. 133, pp. 110852-110852
Closed Access | Times Cited: 24
Amir Abdoli, Hoda Mirzaian Ardakani
Experimental Gerontology (2020) Vol. 133, pp. 110852-110852
Closed Access | Times Cited: 24
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
Eleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114181-114181
Closed Access | Times Cited: 2
Eleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114181-114181
Closed Access | Times Cited: 2
Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes
Scott Cornwall, Matthew E. Wikström, Arthur W. Musk, et al.
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1082028-e1082028
Open Access | Times Cited: 24
Scott Cornwall, Matthew E. Wikström, Arthur W. Musk, et al.
OncoImmunology (2015) Vol. 5, Iss. 2, pp. e1082028-e1082028
Open Access | Times Cited: 24
T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies
Danay Saavedra, Beatriz García Verdecia, Agustín Lage
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 23
Danay Saavedra, Beatriz García Verdecia, Agustín Lage
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 23
<p>Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential</p>
Capucine Baldini, Stéphane Champiat, Perrine Vuagnat, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 2505-2512
Open Access | Times Cited: 20
Capucine Baldini, Stéphane Champiat, Perrine Vuagnat, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 2505-2512
Open Access | Times Cited: 20
The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span
Primož Rožman
GeroScience (2018) Vol. 40, Iss. 3, pp. 221-242
Open Access | Times Cited: 18
Primož Rožman
GeroScience (2018) Vol. 40, Iss. 3, pp. 221-242
Open Access | Times Cited: 18
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer
Gisela María Suárez, Ana Laura Añé-Kourí, Amnely González, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 6, pp. 1735-1743
Open Access | Times Cited: 12
Gisela María Suárez, Ana Laura Añé-Kourí, Amnely González, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 6, pp. 1735-1743
Open Access | Times Cited: 12
Immunotherapy and Complexity: Overcoming Barriers to Control of Advanced Cancer
Agustin Lage
MEDICC Review (2014) Vol. 16, Iss. 3-4, pp. 65-65
Open Access | Times Cited: 8
Agustin Lage
MEDICC Review (2014) Vol. 16, Iss. 3-4, pp. 65-65
Open Access | Times Cited: 8
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer
Rosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.
Immunotherapy (2020) Vol. 13, Iss. 1, pp. 67-77
Closed Access | Times Cited: 7
Rosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.
Immunotherapy (2020) Vol. 13, Iss. 1, pp. 67-77
Closed Access | Times Cited: 7
Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
Hsiao‐Ling Chen, Vinson Wai‐Shun Chan, Yu‐Kang Tu, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1484-1484
Open Access | Times Cited: 5
Hsiao‐Ling Chen, Vinson Wai‐Shun Chan, Yu‐Kang Tu, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1484-1484
Open Access | Times Cited: 5
The Aging Immune System
Ludmila Müller, Graham Pawelec
Elsevier eBooks (2015), pp. 407-431
Closed Access | Times Cited: 3
Ludmila Müller, Graham Pawelec
Elsevier eBooks (2015), pp. 407-431
Closed Access | Times Cited: 3
Effect of Age on Safety and Efficacy of Novel Cancer Drugs Investigated in Early-Phase Clinical Trials
Eleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
(2024)
Closed Access
Eleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
(2024)
Closed Access
Immunosenescence and Cancer Immunotherapy at Old Age: Basics
Tamàs Fülöp, Juliana Witkowski, K. Hirokawa, et al.
Springer eBooks (2018), pp. 1-20
Closed Access | Times Cited: 3
Tamàs Fülöp, Juliana Witkowski, K. Hirokawa, et al.
Springer eBooks (2018), pp. 1-20
Closed Access | Times Cited: 3
Assessment of non-classical lymphocyte populations in patients with advanced lung cancer treated with Biomodulina T following platinum-based chemotherapy
Gisela María Suárez, Mauricio Catalá, Yadira Peña, et al.
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 433-445
Open Access
Gisela María Suárez, Mauricio Catalá, Yadira Peña, et al.
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 433-445
Open Access
How Could We Slow or Reverse the Human Aging Process and Extend the Healthy Life Span with Heterochronous Autologous Hematopoietic Stem Cell Transplantation
Primož Rožman
Rejuvenation Research (2019) Vol. 23, Iss. 2, pp. 159-170
Closed Access | Times Cited: 3
Primož Rožman
Rejuvenation Research (2019) Vol. 23, Iss. 2, pp. 159-170
Closed Access | Times Cited: 3
Amelioration Effect of a Tertiary Sulfonium Compound, Dimethylsulfoniopropionate, in Green Sea Algae on Ehrlich Ascitic-tumor, Solid Tumor and Related Diseases
Kenji Nakajima
Springer eBooks (2014), pp. 205-238
Closed Access | Times Cited: 2
Kenji Nakajima
Springer eBooks (2014), pp. 205-238
Closed Access | Times Cited: 2
